Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macula; Degeneration”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT03197493
What this trial is testing

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macula; DegenerationRetina
Snyder, Robert W., M.D., Ph.D., P.C. 35
Testing effectiveness (Phase 2)Study completedNCT00390208
What this trial is testing

Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Bay Area Retina Associates 60
Post-approval studies (Phase 4)Looking for participantsNCT06875245
What this trial is testing

Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

Who this might be right for
Wet Age-related Macular Degeneration
Faculty Hospital Kralovske Vinohrady 100
Not applicableEnrolling By InvitationNCT04607369
What this trial is testing

Implementation of the NEDS EyeCTester App

Who this might be right for
Optic Nerve DiseaseMacular DiseaseVisual Pathway Disorder
Neuro-Eye Diagnostic Systems, LLC 100
Not applicableStudy completedNCT05208879
What this trial is testing

CArotenoid in hypoChOlesterolemia

Who this might be right for
Primary Intestinal HypocholesterolemiaAbetalipoproteinemiaChylomicron Retention Disease
Hospices Civils de Lyon 10
Not applicableStudy completedNCT03278262
What this trial is testing

The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

Who this might be right for
Wet Macular Degeneration
Bayer 2,312
Post-approval studies (Phase 4)UnknownNCT02321267
What this trial is testing

Cohort Study of the Clinical Course of Macular Diseases in Kagawa

Who this might be right for
Macular Disease
Kagawa University 1,000
Not applicableStudy completedNCT01510392
What this trial is testing

CEI Van Outreach Screening Study

Who this might be right for
GlaucomaMacular DiseaseKeratoconus
Oregon Health and Science University 118
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Not applicableUnknownNCT03528122
What this trial is testing

Amniotic Membrane for Recurrent Macular Hole

Who this might be right for
Macula HoleRetinal DetachmentMyopic Macular Degeneration
Minia University 20
Large-scale testing (Phase 3)Ended earlyNCT00505947
What this trial is testing

Treatment of Refractory Diabetic Macular Edema With Infliximab

Who this might be right for
Diabetic Macular EdemaVisual AcuityDiabetic Retinopathy
University of Athens 12
Not applicableNot Yet RecruitingNCT05507840
What this trial is testing

Photobiomodulation for Dry Age Related Macula Degeneration

Who this might be right for
PhotobiomodulationAge-Related Macular Degeneration
Oslo University Hospital 121
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Testing effectiveness (Phase 2)Study completedNCT01284478
What this trial is testing

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Who this might be right for
Pseudophakic Cystoid Macular Edema,Diabetic Macular Edema
Northern California Retina Vitreous Associates 6
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableUnknownNCT05056025
What this trial is testing

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

Who this might be right for
AMDSoft DrusenReticular Pseudodrusen+2 more
Institut de la Macula y la Retina 48
Not applicableStudy completedNCT01603823
What this trial is testing

Angiographie and OCT in Macula and Retinal Diseases

Who this might be right for
Macular Edema
Medical University of Vienna 30
Not applicableUnknownNCT03517241
What this trial is testing

Objective Assessment of Macular Function at Retinal and Cortical Levels

Who this might be right for
Macula; Degeneration, Congenital or HereditaryRetina Disorder
Medical University of Vienna 100
Testing effectiveness (Phase 2)UnknownNCT01278277
What this trial is testing

Saffron Supplementation in Stargardt's Disease

Who this might be right for
Retinal DegenerationGenetic DiseaseSingle-Gene Defects+1 more
Catholic University of the Sacred Heart 30
Load More Results